Synergistic interaction between felbamate and lamotrigine against seizures induced by 4-ammopyridine and pentylenetetrazole in mice

被引:10
作者
Cuadrado, A [1 ]
Bravo, J [1 ]
Armijo, JA [1 ]
机构
[1] Univ Cantabria, Sch Med, Marques Valdecilla Univ Hosp, Clin Pharmacol Serv,Dept Physiol & Pharmacol, E-39008 Santander, Spain
关键词
felbamate; lamotrigine; pentylenetetrazole; 4-aminopyridine; drug interaction;
D O I
10.1016/S0014-2999(03)01460-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We compared the effects of adding a nonprotective dose of felbamate to increasing single doses of lamotrigine with those of monotherapy and vice versa in CD1 mice. Anticonvulsant effects were evaluated against seizures induced by both 14 mg/kg of 4-aminopyridine and 110 mg/kg of pentylenetetrazole, and neurotoxic effects were evaluated by the rotarod test. Changes in anticonvulsants, gamma-aminobutyric acid (GABA) and glutamate concentrations in the whole brain were also assessed. Lamotrigine increased the potency ratio of felbamate against 4-aminopyridine (1.80, 95% confidence interval (CI) 1.23-2.65, P<0.05) but not against pentylenetetrazole nor on rotarod, the protective index being increased from 12.0 to 17.1 for 4-aminopyridine, with a reduction in brain felbamate, and with an increase in brain GABA. Felbamate increased the potency ratio of lamotrigine against 4-aminopyridine (4.35, 95% Cl 2.05-9.25, P<0.05) but not on rotarod, the protective index being increased from 4.4 to 15.7; there were no changes in brain lamotrigine, and changes in brain GABA and/or glutamate were unrelated to the pharmacodynamic effects. In conclusion, a nonprotective dose of lamotrigine increased the therapeutic index of felbamate and vice versa, and these effects appeared to be pharmacodynamic. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:43 / 52
页数:10
相关论文
共 47 条
[1]  
Arzimanoglou A, 2001, REV NEUROL-FRANCE, V157, P525
[2]   ANTICONVULSANT POTENCY AND NEUROTOXICITY OF VALPROATE ALONE AND IN COMBINATION WITH CARBAMAZEPINE OR PHENOBARBITAL [J].
BOURGEOIS, BFD .
CLINICAL NEUROPHARMACOLOGY, 1988, 11 (04) :348-359
[3]  
BOURGEOIS BFD, 1988, J PHARMACOL EXP THER, V247, P1128
[4]   Lamotrigine substitution study: Evidence for synergism with sodium valproate? [J].
Brodie, MJ ;
Yuen, AWC .
EPILEPSY RESEARCH, 1997, 26 (03) :423-432
[5]   PHARMACODYNAMIC INTERACTIONS BETWEEN PHENYTOIN AND VALPROATE - INDIVIDUAL AND COMBINED ANTIEPILEPTIC AND NEUROTOXIC ACTIONS IN MICE [J].
CHEZ, MG ;
BOURGEOIS, BFD ;
PIPPENGER, CE ;
KNOWLES, WD .
CLINICAL NEUROPHARMACOLOGY, 1994, 17 (01) :32-37
[6]   The long-term use of felbamate in children with severe refractory epilepsy [J].
Cilio, MR ;
Kartashov, AI ;
Vigevano, F .
EPILEPSY RESEARCH, 2001, 47 (1-2) :1-7
[7]   Effect of felbamate on the pharmacokinetics of lamotrigine [J].
Colucci, R ;
Glue, P ;
Holt, B ;
Banfield, C ;
Reidenberg, P ;
Meeahn, JW ;
Pai, S ;
Nomeir, A ;
Lim, J ;
Lin, CC ;
Affrime, MB .
JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 36 (07) :634-638
[8]   KAINIC ACID AND 4-AMINOPYRIDINE SEIZURE MODELS IN MICE - EVALUATION OF EFFICACY OF ANTIEPILEPTIC AGENTS AND CALCIUM-ANTAGONISTS [J].
CRAMER, CL ;
STAGNITTO, ML ;
KNOWLES, MA ;
PALMER, GC .
LIFE SCIENCES, 1994, 54 (16) :PL271-PL275
[9]   Synergistic interaction between valproate and lamotrigine against seizures induced by 4-aminopyridine and pentylenetetrazole in mice [J].
Cuadrado, A ;
de las Cuevas, I ;
Valdizán, EM ;
Armijo, JA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 453 (01) :43-52
[10]  
Czuczwar SJ, 2001, POL J PHARMACOL, V53, P65